News Author: Andrew D. Bowser Publish date: June 28, 2018
CHICAGO – The OPTIMISMM study examined patients who had received at least two prior cycles of lenalidomide.
News Author: Andrew D. Bowser Publish date: June 27, 2018
CHICAGO – Could liso-cel be the next CAR T-cell therapy to compete in DLBCL?
News Author: Andrew D. Bowser Publish date: June 26, 2018
A 1% cream formulation of Xepi cream (ozenoxacin) had a clinical and microbiologic response that was rapid and su...
News Author: Andrew D. Bowser Publish date: June 26, 2018
While the Supreme Court has struck down a Texas law requiring abortion facilities to meet ASC standards, 13 states still require abortions to be pr...
News Author: Andrew D. Bowser Publish date: June 24, 2018
CHICAGO—A novel CD19-targeted T-cell therapy induced complete metabolic responses (CMRs) and no cytokine release syndrome (CRS) in patients with B-cel...
News Author: Andrew D. Bowser Publish date: June 23, 2018
Policy to abate the opioid crisis must go beyond the medical model to incorporate socioenvironmental disadvantage factors and health behaviors.
News Author: Andrew D. Bowser Publish date: June 21, 2018
CHICAGO – Dr. S. Vincent Rajkumar and Dr. Rafael Fonseca faced off in a debate over the value of multiple myeloma...
News Author: Andrew D. Bowser Publish date: June 21, 2018
Most evidence supporting this hypothesis comes from animal studies.
News Author: Andrew D. Bowser Publish date: June 21, 2018
Other reasons that ranked high were appeals to the vaccine’s lasting benefit and safety.
News Author: Andrew D. Bowser Publish date: June 20, 2018
Nearly half of Parkinson’s disease patients reported having an impulse control disorder during a 5-year period.
News Author: Andrew D. Bowser Publish date: June 20, 2018
CHICAGO – Frontline use of chemoimmunotherapy is complicated.
News Author: Andrew D. Bowser Publish date: June 20, 2018
Most providers perceived an improvement in their ability to communicate with families about appropriate antibiotic use and the need for testing.
News Author: Andrew D. Bowser Publish date: June 19, 2018
CHICAGO—A specific gene signature might be able to identify patients at risk of CD19 CAR T-cell associated neurotoxicity, according to results of an e...
News Author: Andrew D. Bowser Publish date: June 17, 2018
CHICAGO—Prior exposure to blinatumomab does not appear to affect the successful manufacture of KTE-C19 or its efficacy in patients with relapsed/refra...
News Author: Andrew D. Bowser Publish date: June 16, 2018
The findings help inform the off-label prescribing of antipsychotics in children and adolescents, researchers said.
